Tobacco, Alcohol, Prescription Medication, and Other Substance Use Screening
The TAPS Tool, developed by a study team in the NIDA Clinical Trials Network (CTN-0059), is a 2-step screening and brief assessment approach. TAPS-1, the screening component, asks about frequency of use of tobacco, alcohol (above guideline-recommended daily limits), illicit drugs, and nonmedical use of prescription medications within the previous 12 months. If the participants reports having used one of the substances, TAPS-2 then asks more specific follow-up questions regarding use in the past 3 months
Prescription Opioid Misuse Index
This 6-item interview is focused specifically on prescription opioid use behaviors. It was developed and used in a larger study designed to assess correlates of OxyContin abuse in pain patients prescribed OxyContin, patients treated for OxyContin addiction, and individuals incarcerated for OxyContin-related charges. The original 8-item POMI included questions regarding dose, frequency of use, the need for early refills, a doctor expressing concern of misuse, feeling high from the medication, taking medication due to stress, obtaining prescriptions from multiple physicians, and pain control. It also included a question regarding adequate pain relief to confirm that any increase in prescription use reported was not due to inadequate pain control.
CTN-0075 CRF SAS Data
CTN-0075 CRF CSV Data
Treatment Satisfaction Survey
Satisfaction with treatment delivery by participants will be measured using the Treatment Satisfaction Survey (adapted from Harland et al., 2005) at each visit. The proportion of visits in which participants are satisfied (score of 4 on a Likert Scale of 1-5) or very satisfied (score of 5 on a Likert Scale of 1-5) will be calculated.